European Archives - Page 1088 of 1303 - European Medical Journal

Biosimilars and Switching: What is your Perspective?

The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases.

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting The ‘Nocebo’ Effect

Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.

Rheumatosphere: Reach New Heights in Diagnosis and Treatment of Arthritis by Engaging, Empowering, and Inspiring

Rheumatosphere is an initiative started in Glasgow, UK, in 2012; its aim is to raise awareness about arthritis and arthritis-related research.

The Patient’s Perspective on Psoriatic Arthritis: What more can Rheumatologists do to Optimise Disease Management?

The symposium at the EULAR 2017 congress aimed to provide insights into the burden of psoriatic arthritis on patients’ daily lives, including the…

Longitudinal Analysis of the Gastrointestinal Microbiota in Systemic Sclerosis

Understanding the interplay between the immune system and gastrointestinal tract microbiota is an evolving area of research.

Drug Trough Levels and Antidrug Antibodies in Nonselected Ankylosing Spondylitis Patients Using Subcutaneous Anti-TNF Drugs

Immunisation of biological drugs can result in reduced efficacy of treatment and an increased risk of adverse effects.

Editor’s Pick: Why do Diseases Start One Sided? Clues From HLA-B27 Acute Anterior Uveitis

Uveitis is an inflammatory disease with significant disease burden, as it causes ≤10% of legal blindness in the USA.

Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential

In this review, the role of the organic osmolytes taurine, betaine, myo-inositol, and sorbitol in skeletal muscles in general, and in myositis in…

Sleep Disorders in Fibromyalgia Patients: The Role of Autonomic Nervous System Dysfunction

Fibromyalgia is characterised by chronic musculoskeletal pain, autonomic nervous system dysfunction, and disturbed sleep.

Serum Urate as a Surrogate Endpoint for Flares in People with Gout: A Systematic Review and Meta-Regression Analysis

The OMERACT gout group has, for several years, been working towards a model for evaluating a biomarker as surrogate endpoint for clinically relevant outcomes.